Estimated market cap $5.60BShares outstanding from the company’s latest SEC filing (all share classes, each priced at its own close; ADRs converted to ADS) × last close from Tiingo. Updated daily. This figure: shares as of Oct 30, 2026, last close Nov 13, 2026.45.54M shares, shares as of Oct 30, 2026CIK 313143The SEC’s Central Index Key, the number it uses to identify every company and person that files.
Insider trades, 12 mo
0 buys · 1 sell
$101.1K sold, open market
Congress trades, 24 mo
—
No disclosed trades
13F holders
…
Lobbying, 12 mo
—
No lobbying filings
Federal contracts, 12 mo
—
None matched
Ask your AI:
Latest 10-Q
What changed in Haemonetics Corporation's latest quarterly report, compared with the one before.
Loading…
Insider trades
Open-market trades from Form 4. 10b5-1 marks a plan set in advance.Open-market buys and sales by officers, directors and 10% owners, from SEC Form 4. A plan set in advance is marked 10b5-1.
Loading…
13F holders
Funds that report this stock, checked against market prices.Fund managers with over $100 million in US-listed stocks file a 13F each quarter, up to 45 days after quarter end. Long positions only.
Loading…
Top 10 holders.Premium lists every holder, with CSV downloads.
Disclosed in dollar ranges, up to 45 days after the trade.Members of Congress, their spouses and dependent children report trades in dollar ranges, up to 45 days after the trade.
Loading…
Lobbying
What Haemonetics Corporation and its lobbying firms report each quarter.A company that lobbies with its own staff reports its expenses; a lobbying firm it hires reports the income it received. We count both.
Loading…
H-1B labor applications at Haemonetics Corporation
3 certified in 12 mo
Labor condition applications decided by the Department of Labor, matched to Haemonetics Corporation by employer name. An application is not a hire.
Median yearly wage offered, full-time certified applications, Jul 2025 to Jun 2026: —The wage the employer offered, as filed, with its unit. The yearly figure restates it per year (hourly x 2,080, weekly x 52, every two weeks x 26, monthly x 12) from the low end of the offered range. It is not what the worker was paid.
H-1B labor applications decided at Haemonetics Corporation by quarter
We match the employer's name to a public company automatically, including a reviewed list of subsidiaries. A subsidiary can be missed and a similar name can be matched wrongly. The files carry no worker names.
Institutional ownership over time
How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.
13F holders, Q3 2026Fund managers with over $100 million in US-listed stocks file a 13F each quarter, up to 45 days after quarter end. Long positions only.
248
71.8% of shares · 73 added
Latest 10-Q
Q3 2026
What changed in Haemonetics Corporation's latest quarterly report, compared with the one before.
Filed Nov 5, 2026 · Quarter ended Sep 26, 2026
AI No AI summary for this 10-Q: management's discussion could not be compared, and the other sections did not change.
Compared with the 10-Q for the quarter ended Jun 27, 2026. Sections compared: risk factors and legal proceedings.
Open-market trades from Form 4. 10b5-1 marks a plan set in advance.Open-market buys and sales by officers, directors and 10% owners, from SEC Form 4. A plan set in advance is marked 10b5-1.
Recent insider trades
How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss.
248 funds report HAE. Values checked against market prices.Fund managers with over $100 million in US-listed stocks file a 13F each quarter, up to 45 days after quarter end. Long positions only.
Funds report more than 100% of shares (Q2 2026)Fund managers with more than $100 million in US-listed stocks file a 13F each quarter. It lists their long stock positions only (shorts, options and bonds are left out) and can arrive up to 45 days after the quarter ends, so this is a snapshot of the quarter end. We add up the shares every fund reports in this class and divide by the shares outstanding. The total can pass 100%: the same shares are often reported by more than one manager (an adviser and the fund it runs), lent shares can be reported twice, and the share count can be out of date after buybacks. We divided 49.65M reported shares by 45.50M shares, from the company’s SEC filing as of Jul 31, 2026.
330 funds hold the stock.
Q3 2026: 72% · 5,560 of ~8,900 funds reported so farFunds have 45 days after a quarter ends to file. This quarter’s reports are still arriving, so the figure only counts the funds that have filed so far and will usually rise.
Q2 2025>100%
Q3 2025>100%
Q4 2025>100%
Q1 2026>100%
Q2 2026>100%
Q3 2026 (so far)72%
Q3 2026. 40 new, 73 added to, 98 trimmed, 124 exited since Q2 2026.
Download CSVEvery fund that holds HAE, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Trades by members of Congress
Disclosed in dollar ranges, up to 45 days after the trade.Members of Congress, their spouses and dependent children report trades in dollar ranges, up to 45 days after the trade.
Recent congressional trades
How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss.
What Haemonetics Corporation and its lobbying firms report each quarter.A company that lobbies with its own staff reports its expenses; a lobbying firm it hires reports the income it received. We count both.
No recent lobbying filings for this company.
Institutional ownership over time
How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.
Funds holding the stock
Shares they report
Funds holding the stock by quarter
Q2 2013
193
—
52.24M
$2.2B
Q3 2013
191
-2
56.50M
$2.3B
Q4 2013
193
+2
54.80M
$2.3B
Q1 2014
189
-4
54.11M
$1.8B
Q2 2014
174
-15
55.36M
$2.0B
Q3 2014
169
-5
53.08M
$1.9B
Q4 2014
173
+4
54.18M
$2.0B
Q1 2015
169
-4
53.75M
$2.4B
Q2 2015
179
+10
53.42M
$2.2B
Q3 2015
171
-8
52.13M
$1.7B
Q4 2015
162
-9
51.14M
$1.6B
Q1 2016
169
+7
51.18M
$1.8B
Q2 2016
178
+9
54.31M
$1.6B
Q3 2016
180
+2
51.79M
$1.9B
Q4 2016
198
+18
53.08M
$2.1B
Q1 2017
181
-17
54.72M
$2.2B
Q2 2017
197
+16
55.47M
$2.2B
Q3 2017
207
+10
54.79M
$2.5B
Q4 2017
246
+39
53.65M
$3.1B
Q1 2018
261
+15
52.85M
$3.9B
Q2 2018
293
+32
51.11M
$4.6B
Q3 2018
292
-1
52.94M
$6.1B
Q4 2018
278
-14
51.47M
$5.1B
Q1 2019
259
-19
51.35M
$4.5B
Q2 2019
256
-3
51.39M
$6.2B
Q3 2019
275
+19
49.79M
$6.3B
Q4 2019
298
+23
50.74M
$5.8B
Q1 2020
269
-29
50.72M
$5.1B
Q2 2020
285
+16
49.60M
$4.4B
Q3 2020
268
-17
49.44M
$4.3B
Q4 2020
286
+18
50.88M
$6.0B
Q1 2021
296
+10
49.60M
$5.5B
Q2 2021
258
-38
50.70M
$3.4B
Q3 2021
246
-12
50.73M
$3.6B
Q4 2021
256
+10
50.19M
$2.7B
Q1 2022
241
-15
51.52M
$3.3B
Q2 2022
241
0
51.97M
$3.4B
Q3 2022
270
+29
51.76M
$3.8B
Q4 2022
294
+24
50.37M
$4.0B
Q1 2023
301
+7
52.66M
$4.3B
Q2 2023
296
-5
50.58M
$4.3B
Q3 2023
296
0
50.72M
$4.5B
Q4 2023
295
-1
51.24M
$4.4B
Q1 2024
298
+3
52.01M
$4.4B
Q2 2024
317
+19
56.03M
$4.6B
Q3 2024
305
-12
56.02M
$4.5B
Q4 2024
308
+3
56.57M
$4.4B
Q1 2025
313
+5
54.26M
$3.4B
Q2 2025
297
-16
55.31M
$4.1B
Q3 2025
301
+4
51.60M
$2.5B
Q4 2025
330
+29
51.72M
$4.1B
Q1 2026
324
-6
47.62M
$2.7B
Q2 2026
331
+7
49.65M
$3.7B
Q3 2026
248
-83
32.72M
$3.5B
Each point is a quarter-end, from Q2 2013 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.
Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.
The history follows the company's current CUSIP number (405024100). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q2 2013) can be later than the stock's first appearance in 13F reports.
Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.
A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.